Polymorphisms of the Genes Encoding Apoproteins A-I, B, C-III, and E and LDL Receptor, and Cholesterol and LDL Metabolism During Increased Cholesterol Intake
Authors:
- 1 January 1997
- journal article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 17 (1) , 38-44
Abstract
Genetic and dietary factors regulate serum cholesterol level, but detailed investigations into their interactions have not been established. We assessed the effects of apoprotein (apo) E phenotype and polymorphic alleles of the apo A-I, apo B, apo C-III, and LDL receptor genes, separately and together, on regulation of serum LDL cholesterol level. The study group consisted of 29 middle-aged men, and cholesterol absorption, bile acid, and cholesterol synthesis and LDL apo B kinetics were studied in these men during low- and high-cholesterol diets. The six apo B alleles were identified on the basis ofXbaI,EcoRI, andMspI restriction fragment length polymorphism (RFLP), the apo A-I alleles with theMspI RFLP, and the apo C-III and LDL receptor alleles corresponded to theSstI andPvuII RPLPs of these genes, respectively. During low cholesterol intake, LDL cholesterol levels were similar in all of the genetic groups except for men with apo E2 phenotype. They had significantly (P<.05) lower levels of LDL apo B and cholesterol than men without the ε2 allele. The low values were caused by a significantly higher removal of LDL apo B (apo E2, 0.453±0.03 versus apo E3, 0.312±0.01 pools per day,P<.05). High cholesterol intake increased LDL cholesterol levels in all genetic categories except in the apo E2 phenotype irrespective of the combinations with other polymorphisms. Carriers of the apo B R+ allele (EcoRI site present) presented with the most prominent LDL cholesterol rise (from 2.71±0.14 to 3.37±0.29 mmol/L). In multiple stepwise regression analysis, apo BEcoRI RFLP and apo E phenotypes were the only variables that explained the variability of high cholesterol intake–induced change in LDL cholesterol levels. In summary, in any genetic combination, individuals with the ε2 allele had the lowest LDL cholesterol values and were nonresponders to dietary cholesterol, whereas subjects with the apo B R+ allele had marked LDL elevations, especially in combination with the ε4.Keywords
This publication has 42 references indexed in Scilit:
- Apolipoprotein B gene polymorphisms, lipoproteins and coronary atherosclerosis: A study of young myocardial infarction survivors and healthy population-based individualsAtherosclerosis, 1992
- Variation of apolipoprotein B gene is associated with myocardial infarction and lipoprotein levels in DanesAtherosclerosis, 1991
- Normal Plasma Cholesterol in an 88-Year-Old Man Who Eats 25 Eggs a DayNew England Journal of Medicine, 1991
- Association of DNA polymorphism at the apolipoprotein B gene locus with coronary heart disease and serum very low density lipoprotein levels.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990
- Identification of a deletion in the LDL receptor gene A Finnish type of mutationFEBS Letters, 1988
- DNA polymorphisms of the gene for apolipoprotein B in patients with peripheral arterial diseaseAtherosclerosis, 1988
- Apolipoprotein B gene variants are involved in the determination of serum cholesterol levels: a study in normo- and hypelipidaemic individualsAtherosclerosis, 1987
- Apolipoprotein B–Gene DNA Polymorphisms Associated with Myocardial InfarctionNew England Journal of Medicine, 1986
- DNA polymorphism at the apolipoprotein B locus is associated with lipoprotein levelClinical Genetics, 1986
- The metabolism of very low density lipoprotein proteins I. Preliminary in vitro and in vivo observationsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1972